Drug Profile
NCX 2111
Latest Information Update: 31 Jul 2012
Price :
$50
*
At a glance
- Originator NicOx
- Class Antispasmodics; Nitrates; Salicylic acids
- Mechanism of Action Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Overactive bladder
Most Recent Events
- 27 Jul 2012 Discontinued - Preclinical for Overactive bladder in France (unspecified route)
- 03 Dec 2003 No development reported - Preclinical for Overactive bladder in France (unspecified route)
- 04 Oct 2001 New profile